Rebecca Riggins: all publications

• Publications

  • Bouker K, Skaar T, Harburger D, Riggins R, Fernandez D, Zwart A, Clarke R. The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines. Cancer genetics and cytogenetics 175 (1) , 61-4 (2007) PubMed ID:(17498560)

  • Gomez B, Riggins R, Shajahan A, Klimach U, Wang A, Crawford A, Zhu Y, Zwart A, Wang M, Clarke R. Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 21 (14) , 4013-27 (2007) (Epub 27 Jul 2007) PubMed ID:(17660348)

  • Riggins R, Schrecengost R, Guerrero M, Bouton A. Pathways to tamoxifen resistance. Cancer letters 256 (1) , 1-24 (2007) (Epub 01 May 2007) PubMed ID:(17475399)

  • Schrecengost R, Riggins R, Thomas K, Guerrero M, Bouton A. Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling. Cancer research 67 (13) , 6174-82 (2007) PubMed ID:(17616674)

  • Riggins R, Thomas K, Ta H, Wen J, Davis R, Schuh N, Donelan S, Owen K, Gibson M, Shupnik M, Silva C, Parsons S, Clarke R, Bouton A. Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. Cancer research 66 (14) , 7007-15 (2006) PubMed ID:(16849545)

  • Bouker K, Skaar T, Riggins R, Harburger D, Fernandez D, Zwart A, Wang A, Clarke R. Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis 26 (9) , 1527-35 (2005) (Epub 05 May 2005) PubMed ID:(15878912)

  • Riggins R, Bouton A, Liu M, Clarke R. Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer. Vitamins and hormones 71 , 201-37 (2005) PubMed ID:(16112269)

  • Riggins R, Zwart A, Nehra R, Clarke R. The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells. Molecular cancer therapeutics 4 (1) , 33-41 (2005) PubMed ID:(15657351)

  • Bouker K, Skaar T, Fernandez D, O'Brien K, Riggins R, Cao D, Clarke R. interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant). Cancer research 64 (11) , 4030-9 (2004) PubMed ID:(15173018)

  • Hilakivi-Clarke L, Wang C, Kalil M, Riggins R, Pestell R. Nutritional modulation of the cell cycle and breast cancer. Endocrine-related cancer 11 (4) , 603-22 (2004) PubMed ID:(15613442)

Results